ID

13780

Beschreibung

N-Acetylcysteine for Neuroprotection in Parkinson's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT01470027

Link

https://clinicaltrials.gov/show/NCT01470027

Stichworte

  1. 06.03.16 06.03.16 -
Hochgeladen am

6. März 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Parkinson Disease NCT01470027

Eligibility Parkinson Disease NCT01470027

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of idiopathic pd according to the united kingdom parkinson's disease society brain bank criteria (ukpdsbb) criteria (only for pd group
Beschreibung

idiopathic parkinson disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0865475
age 50 to 75 years
Beschreibung

age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
able to give informed consent for study participation
Beschreibung

informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
not on any medication for pd (anticholinergic agents allowed)
Beschreibung

medication Parkinson Disease; Anticholinergic Agents

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0030567
UMLS CUI [2]
C0242896
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
unable to give informed consent
Beschreibung

informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
unable to undergo a brain mri
Beschreibung

brain mri

Datentyp

boolean

Alias
UMLS CUI [1]
C0412675
pd duration ≥15 years
Beschreibung

disease duration Parkinson Disease

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0872146
UMLS CUI [1,2]
C0030567
receiving dopamine receptor blocking agents, including typical neuroleptics, prochlorperazine, and metoclopramide
Beschreibung

neuroleptics; prochlorperazine; metoclopramide

Datentyp

boolean

Alias
UMLS CUI [1]
C0040615
UMLS CUI [2]
C0033229
UMLS CUI [3]
C0025853
diagnosis of major depression or other axis i psychopathology
Beschreibung

major depression

Datentyp

boolean

Alias
UMLS CUI [1]
C1269683
modified mini-mental status exam (mmse) ≤ 24/30
Beschreibung

Mini-mental state examination

Datentyp

boolean

Alias
UMLS CUI [1]
C0451306
diagnosis of chronic or persistent illnesses that could affect oxidative stress status, such as diabetes or congestive heart failure
Beschreibung

diabetes; congestive heart failure

Datentyp

boolean

Alias
UMLS CUI [1]
C0011847
UMLS CUI [2]
C0018802
significant concomitant medical disease limiting life expectancy to less than 12 months from study inclusion
Beschreibung

life expectancy limited comorbidity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0023671
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
diagnosis of primary mitochondrial disorder, epilepsy, stroke, multiple sclerosis or other neurodegenerative diseases such as alzheimer's disease or als
Beschreibung

Mitochondrial Diseases; epilepsy; stroke; multiple sclerosis; Alzheimers Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0751651
UMLS CUI [2]
C0014544
UMLS CUI [3]
C0038454
UMLS CUI [4]
C0026769
UMLS CUI [5]
C0002395

Ähnliche Modelle

Eligibility Parkinson Disease NCT01470027

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
idiopathic parkinson disease
Item
diagnosis of idiopathic pd according to the united kingdom parkinson's disease society brain bank criteria (ukpdsbb) criteria (only for pd group
boolean
C0865475 (UMLS CUI [1])
age
Item
age 50 to 75 years
boolean
C0001779 (UMLS CUI [1])
informed consent
Item
able to give informed consent for study participation
boolean
C0021430 (UMLS CUI [1])
medication Parkinson Disease; Anticholinergic Agents
Item
not on any medication for pd (anticholinergic agents allowed)
boolean
C0013227 (UMLS CUI [1,1])
C0030567 (UMLS CUI [1,2])
C0242896 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
informed consent
Item
unable to give informed consent
boolean
C0021430 (UMLS CUI [1])
brain mri
Item
unable to undergo a brain mri
boolean
C0412675 (UMLS CUI [1])
disease duration Parkinson Disease
Item
pd duration ≥15 years
boolean
C0872146 (UMLS CUI [1,1])
C0030567 (UMLS CUI [1,2])
neuroleptics; prochlorperazine; metoclopramide
Item
receiving dopamine receptor blocking agents, including typical neuroleptics, prochlorperazine, and metoclopramide
boolean
C0040615 (UMLS CUI [1])
C0033229 (UMLS CUI [2])
C0025853 (UMLS CUI [3])
major depression
Item
diagnosis of major depression or other axis i psychopathology
boolean
C1269683 (UMLS CUI [1])
Mini-mental state examination
Item
modified mini-mental status exam (mmse) ≤ 24/30
boolean
C0451306 (UMLS CUI [1])
diabetes; congestive heart failure
Item
diagnosis of chronic or persistent illnesses that could affect oxidative stress status, such as diabetes or congestive heart failure
boolean
C0011847 (UMLS CUI [1])
C0018802 (UMLS CUI [2])
life expectancy limited comorbidity
Item
significant concomitant medical disease limiting life expectancy to less than 12 months from study inclusion
boolean
C0023671 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
Mitochondrial Diseases; epilepsy; stroke; multiple sclerosis; Alzheimers Disease
Item
diagnosis of primary mitochondrial disorder, epilepsy, stroke, multiple sclerosis or other neurodegenerative diseases such as alzheimer's disease or als
boolean
C0751651 (UMLS CUI [1])
C0014544 (UMLS CUI [2])
C0038454 (UMLS CUI [3])
C0026769 (UMLS CUI [4])
C0002395 (UMLS CUI [5])

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video